Munich - Delayed Quote EUR

Fresenius Medical Care AG & Co. KGaA (FMEA.MU)

20.60

-0.60

(-2.83%)

At close: November 26 at 5:26 PM GMT+1

Fresenius Medical Care AG's (ETR:FME) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Fresenius Medical Care's (ETR:FME) stock is up by a considerable 20% over the past three months. We, however wanted to...

Simply Wall St. 4 days ago

FMCQF

FMS
Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced its heart and lung group has been awarded a national group purchasing agreement for Mechanical Circulatory Support with Premier, Inc in the U.S. Since acquiring Xenios in 2016, Fresenius Medical Care has been dedicated to advancing heart and lung therapy. The agreement underscores FME's commitment to critical care solutions and allows Premier member hospitals a

PR Newswire 7 days ago

FMCQF

FMS
Fresenius Medical Care Sees Strong Q3 Margin Growth

Fresenius Medical Care (FMS) has released an update. Fresenius Medical Care reported robust growth in its operating income margin for Q3 2024, driven by organic revenue growth and improved U.S. dialysis treatment volumes. The company exceeded its FME25 savings target, achieving significant cost reductions, and further optimized its portfolio by divesting non-core assets. With a positive outlook, Fresenius continues to focus on enhancing operational performance and financial stability. For furthe

TipRanks 20 days ago

FMCQF

FMS
Fresenius Medical Care (ETR:FME) Is Finding It Tricky To Allocate Its Capital

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

Simply Wall St. 20 days ago

FMCQF

FMS
Fresenius Medical Care Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Fresenius Medical Care ( ETR:FME ) Third Quarter 2024 Results Key Financial Results Revenue: €4.76b (down 3.6% from 3Q...

Simply Wall St. 20 days ago

FMCQF

FMS
Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

"In the third quarter, we continued the improvement of our financial performance, recording a meaningful progress in the operating income margin towards our 2025 margin targets. The Care Delivery margin extended well into the 2025 margin target band while Care Enablement maintained the significant margin progress realized in the first half year. Our clear focus on improving operational performance and continued momentum of FME25 savings realization supported our progress in the third quarter", s

PR Newswire 21 days ago

FMCQF

FMS
Fresenius Medical Care Profit Beats Market Views

The dialysis company stuck to its guidance for the year after profit soared ahead of analysts’ expectations.

The Wall Street Journal 21 days ago

FMCQF

FMS
Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 25 days ago

NGG

NGGTF

YUMC
Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the presentation of nearly 75 company-affiliated research abstracts at the American Society of Nephrology's (ASN) Kidney Week 2024 taking place October 24-27 in San Diego.

PR Newswire last month

FMCQF

FMS
Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last three years, but the stock advances 4.8% this past week

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Simply Wall St. last month

FMCQF

FMS
Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Fresenius Medical Care (FME), a global leader in kidney care, has achieved a growth milestone of more than 14,000 U.S.-based patients using the Company's NxStage systems to perform Home Hemodialysis (HHD) therapy through both Fresenius Kidney Care clinics and other providers. The company has in parallel launched the newest version of its home dialysis machine, the NxStage® Versi®HD with GuideMe Software, featuring enhancements designed to simplify treatment, increase ease of learning, and improv

PR Newswire 2 months ago

FMCQF

FMS
Some Investors May Be Willing To Look Past Fresenius Medical Care's (ETR:FME) Soft Earnings

Investors were disappointed with the weak earnings posted by Fresenius Medical Care AG ( ETR:FME ). Despite the soft...

Simply Wall St. 3 months ago

FMCQF

FMS
Fresenius Medical Care AG Just Missed EPS By 95%: Here's What Analysts Think Will Happen Next

Fresenius Medical Care AG ( ETR:FME ) missed earnings with its latest half-yearly results, disappointing...

Simply Wall St. 3 months ago

FMCQF

FMS
Fresenius Medical Care Second Quarter 2024 Earnings: Misses Expectations

Fresenius Medical Care ( ETR:FME ) Second Quarter 2024 Results Key Financial Results Revenue: €4.77b (down 1.2% from 2Q...

Simply Wall St. 3 months ago

FMCQF

FMS
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

"In the second quarter, we further improved our financial performance while executing against our strategic plan and the company transformation. This quarter is another important proof point for the operational turnaround as we remain focused to deliver on our targets", said Helen Giza, Chief Executive Officer of Fresenius Medical Care AG. "Our operating income margin progressed toward our 2025 margin target band, as Care Enablement increased its profitability. In Care Delivery, U.S. same market

PR Newswire 3 months ago

FMCQF

FMS
Is Now The Time To Look At Buying Fresenius Medical Care AG (ETR:FME)?

Today we're going to take a look at the well-established Fresenius Medical Care AG ( ETR:FME ). The company's stock...

Simply Wall St. 4 months ago

FMCQF

FMS
Institutional owners may consider drastic measures as Fresenius Medical Care AG's (ETR:FME) recent €719m drop adds to long-term losses

Key Insights Given the large stake in the stock by institutions, Fresenius Medical Care's stock price might be...

Simply Wall St. 5 months ago

FMCQF

FMS
Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, has signed five virtual power purchase agreements (vPPAs) with wind and solar energy project developers in Germany and the U.S. The projects are expected to feed around 580 gigawatt hours of renewable energy into the grid, which equals up to 46 percent of FME's most recently reported global consumption. The company is thus taking an important step towards its goal of reducing emiss

PR Newswire 5 months ago

FMCQF

FMS
Fresenius Medical Care (ETR:FME) Will Be Hoping To Turn Its Returns On Capital Around

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Simply Wall St. 5 months ago

FMCQF

FMS
Moody's and S&P change Fresenius Medical Care's rating outlook to stable

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today received from S&P Global, a leading rating agency, the change of its rating outlook to stable from negative (bbb-, stable outlook). Moody's changed the credit rating outlook from negative to stable on May 17 (baa3, stable outlook).

PR Newswire 6 months ago

FMCQF

FMS

Performance Overview

Return	FMEA.MU	DAX P
YTD	+13.71%	+15.19%
1-Year	+18.79%	+20.38%
3-Year	-18.09%	+21.22%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fresenius Medical Care AG & Co. KGaA (FMEA.MU)

Fresenius Medical Care AG's (ETR:FME) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System

Fresenius Medical Care Sees Strong Q3 Margin Growth

Fresenius Medical Care (ETR:FME) Is Finding It Tricky To Allocate Its Capital

Fresenius Medical Care Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Fresenius Medical Care Profit Beats Market Views

Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last three years, but the stock advances 4.8% this past week

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Some Investors May Be Willing To Look Past Fresenius Medical Care's (ETR:FME) Soft Earnings

Fresenius Medical Care AG Just Missed EPS By 95%: Here's What Analysts Think Will Happen Next

Fresenius Medical Care Second Quarter 2024 Earnings: Misses Expectations

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Is Now The Time To Look At Buying Fresenius Medical Care AG (ETR:FME)?

Institutional owners may consider drastic measures as Fresenius Medical Care AG's (ETR:FME) recent €719m drop adds to long-term losses

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

Fresenius Medical Care (ETR:FME) Will Be Hoping To Turn Its Returns On Capital Around

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

Performance Overview